A new paper co-authored by Teresita Padilla-Benavides, assistant professor of molecular biology and biochemistry, is published in the July 2021 issue of the Federation of American Societies for Experimental Biology (FASEB) Journal.
Titled “The molecular and cellular basis of copper dysregulation and its relationship with human pathologies,” the paper explores the role of copper in human disease.
Copper (Cu) is an essential micronutrient involved in critical metabolic reactions and biological functions. In humans, mutations or malfunctions of genes that regulate copper stability in the body may lead to numerous pathologic conditions, severe neurodegenerative conditions, or metabolic diseases.
Copper also plays role in cancer treatment as a component of drugs and a regulator of drug sensitivity and uptake. In this review, Padilla-Benavides and her colleagues provide an overview of the current knowledge of copper metabolism and transport and its relation to various human pathologies.